findmyKOL

Charles Wykoff, MD

Enriched profile

Director of Research, Retina Consultants of Texas; Professor of Clinical Ophthalmology, Houston Methodist Academic Institute · Retina Consultants of Texas

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Bellaire, TX · South Central · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Charles Wykoff is Director of Research, Retina Consultants of Texas; Professor of Clinical Ophthalmology, Houston Methodist Academic Institute at Retina Consultants of Texas. OpenAlex indexes 507 publications with 23,504 citations (h-index 67); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Charles Wykoff, MD, PHD, is Director of Research, Retina Consultants of Texas. The public record shows 507 publications with 23,504 citations (h-index 67), centered on Retinal Diseases and Treatments, Retinal Imaging and Analysis, Retinal and Optic Conditions. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 45 companies.

  • Most recent indexed publication: 2026 · Eye (London, England)
  • Top research focus: Retinal Diseases and Treatments
  • 12 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 45 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)4 trialsDiabetic Complications4 trialsDiabetic Retinopathy / DME4 trialsEdema3 trialsMacular Edema3 trialsRetinal Vein Occlusion2 trialsDiabetic Retinopathy2 trialsDilatation, Pathologic1 trialTelangiectasis1 trialGeographic Atrophy1 trialAtrophy1 trialIschemia1 trialRetinal Diseases1 trialPathologic Processes1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic ConditionsOcular Diseases and Behçet’s SyndromeOphthalmology and Visual Impairment Studies

Drugs & molecules

across trials, industry payments and publications
Eyleageneric · AfliberceptClinical trials—Industry payments56Publications3Syfovregeneric · PegcetacoplanClinical trials—Industry payments51Publications4Beovugeneric · BrolucizumabClinical trials—Industry payments14Publications1Vabysmogeneric · FaricimabClinical trials—Industry payments12Publications2Susvimogeneric · RanibizumabClinical trials—Industry payments11Publications1Izervaygeneric · Avacincaptad pegolClinical trials—Industry payments4Publications2Visudynegeneric · VerteporfinClinical trials—Industry payments1Publications2Ozurdexgeneric · DexamethasoneClinical trials—Industry payments34Publications—Yutiqgeneric · FluocinoloneClinical trials—Industry payments18Publications—EYLEA HDClinical trials—Industry payments16Publications—Xiperegeneric · TriamcinoloneClinical trials—Industry payments15Publications—Enceltogeneric · Revakinagene taroretcelClinical trials—Industry payments9Publications—

Works with

trial sponsors and companies reporting payments
Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments91Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments57Abbvie Inc.Clinical trials—Industry payments51Boehringer Ingelheim International GmbHClinical trials—Industry payments28Genentech, Inc.Clinical trials—Industry payments26Merck Sharp & Dohme LLCClinical trials—Industry payments22EyePoint Pharmaceuticals US, Inc.Clinical trials—Industry payments21Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments21F. Hoffmann-La Roche AGClinical trials—Industry payments19Janssen Research & Development, LLCClinical trials—Industry payments17Genentech USA, Inc.Clinical trials—Industry payments15Neurotech Pharmaceuticals, Inc.Clinical trials—Industry payments14Novartis Pharma AGClinical trials—Industry payments14Alcon Vision LLCClinical trials—Industry payments13Bausch & Lomb Americas Inc.Clinical trials—Industry payments13Janssen Global Services, LLCClinical trials—Industry payments13Topcon Healthcare, Inc.Clinical trials—Industry payments10Allergan, Inc.Clinical trials—Industry payments8Biogen, Inc.Clinical trials—Industry payments8Sanofi Us Services Inc.Clinical trials—Industry payments8Alcon Research LLCClinical trials—Industry payments6Bausch & Lomb, a division of Bausch Health US, LLCClinical trials—Industry payments6Alimera Sciences, Inc.Clinical trials—Industry payments5Ocular Therapeutix, Inc.Clinical trials—Industry payments5Astellas Pharma US IncClinical trials—Industry payments4BioCryst Pharmaceuticals, Inc.Clinical trials—Industry payments4Avirmax Biopharma, IncClinical trials—Industry payments3Charles C Wykoff, PhD, MDClinical trials3Industry payments—Greater Houston Retina ResearchClinical trials3Industry payments—Hexal AGClinical trials—Industry payments3

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
507publications

Distinct works indexed by OpenAlex, matched via ORCID; 39 in PubMed.

23,504citations

Total citations across indexed works.

67h-index

Hirsch index (OpenAlex). i10-index 240.

Clinical & industry

trials, payments and federal funding
12clinical trials

Investigator role on registered studies.

View trials ↓
45companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

45 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    56.1%
    Complement Inhibitor44%
    Pegcetacoplan100%
    Part B, office-administered≥126 patients
    Vascular Endothelial Growth Factor Inhibitor12.2%
    Aflibercept100%
    Part B, office-administered≥333 patients
  • Sensory organs

    43.4%
    Antineovascularisation agents36.3%
    Faricimab-svoa100%
    Part B, office-administered≥35 patients
    Vascular Endothelial Growth Factor Inhibitor6.2%
    Ranibizumab100%
    Part B, office-administered≥69 patients

    + 6 more classes in this area

  • Musculoskeletal

    0.3%
    Cyclooxygenase Inhibitor0.3%
    Ketorolac Tromethamine100%
    Part D≥47 patients
All 6 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 14 Oct 2026

1 congress contribution (2018) across AMCP per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

David M. Brown95Varun Chaudhary50Sobha Sivaprasad48Peter K. Kaiser40Sunir J. Garg39Rishi P. Singh36Hannah J. Yu35Srinivas R. Sadda34Frank G. Holz34Mark Phillips34Tien Yin Wong34Robyn H. Guymer32Sophie J. Bakri30David Sarraf29David S. Boyer29Jeffrey S. Heier28Justis P. Ehlers28Michael S. Ip27Lehana Thabane27James C. Major26Daniel E. Croft26Harry W. Flynn26Arshad M. Khanani25Jamie Reese22Rahul N. Khurana20Sunil K. Srivastava20Muneeswar Gupta Nittala20Ankoor R. Shah19W. Lloyd Clark18David Eichenbaum18Keean Nanji18Jano van Hemert17Wenying Fan17Adrian L. Harris17Mohit Bhandari17William C. Ou16Rui Wang16David Steel16Amy C Schefler15John F. Payne15

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/charles-wykoff-7912702

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    retinaconsultantstexas.com

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Other

    asrs.org/find-a-specialist/profile/5346/Charles-C-Wykoff

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
  • ResearchGate

    researchgate.net/profile/Charles-Wykoff

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • Doximity

    doximity.com/pub/charles-wykoff-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Vitreoretinal Diseases & Surgery Fellowship

    Bascom Palmer Eye Institute

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
  • Ophthalmology Residency

    Bascom Palmer Eye Institute

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
  • MD

    Harvard Medical School

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
  • PhD

    University of Oxford (Marshall Scholarship)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Undergraduate degree

    Massachusetts Institute of Technology (Phi Beta Kappa)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Board certified

    American Board of Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗

Editorial & leadership roles

journal and society appointments
  • Past President (2021-2023)

    Vit-Buckle Society

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Director of Research

    Retina Consultants of Texas

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Director of Research

    Greater Houston Retina Research Foundation (GHRRF)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Chairman

    Research and Clinical Trials Subcommittee, Retina Consultants of America

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Deputy Chair of Ophthalmology

    Blanton Eye Institute, Houston Methodist Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Chair

    Practice Management Committee, ASRS Board of Directors

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Elected member

    Retina Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Elected member

    Macula Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Founding member

    Ophthalmology Retina Editorial Board

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaconsultantstexas.com ↗
  • Chief Medical Editor

    Retina Specialist (publication)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.